Earnings · China A-shares

Chongqing Genrix Biopharmaceutical Co., Ltd. Class A (688443) earnings

Chongqing Genrix Biopharmaceutical Co., Ltd. Class A published its Q3 report on 2026-10-30: net profit +98.08% year on year, +94.84% excluding one-off items. Wave Radar's earnings-quality score is 59 of 100 (Questionable). The stock moved +16.30% in the 3 trading days after the report.

Report
Q3 report
Published
2026-10-30
Period end
2026-09-30
Net profit YoY
+98.08%
Excl. one-offs YoY
+94.84%
Result
Bad / loss
Quality score
59
Quality
Questionable
Open earnings in Wave Radar

Stock move after the report

Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.

AfterReturnvs index
1 day+11.72%—
3 days+16.30%—
7 days+13.36%—
14 days+0.95%—

Report history

Over the last 8 reports, net profit grew year on year in 6 of them. The stock rose in the 3 trading days after 3 of 6 reports (average +3.48%).

ReportPublishedNet profitProfit YoYExcl. one-offs YoYRevenue YoYEPSROE3 days after30 days after30d vs index
2026 Q3 report2026-10-31-¥6.38M+98.08%+94.84%+274.75%-0.02-0.40%+16.30%——
2026 interim report2026-08-31-¥316.16M-9.29%-2.04%+237.29%-0.86-22.14%-4.67%-4.71%+4.63%
2026 Q1 report2026-04-30-¥149.40M-23.76%-6.18%+233.63%-0.41-9.89%-2.18%-29.64%-31.69%
2025 annual report2026-04-30-¥535.65M+32.81%+28.06%+666.66%-1.46-28.90%-2.18%-29.64%-31.69%
2025 Q3 report2025-10-31-¥332.59M+39.12%+32.78%+1562.05%-0.91-17.01%+0.00%-7.85%-3.16%
2025 interim report2025-08-30-¥289.29M+20.07%+12.91%+358429.65%-0.79-14.62%+6.75%-12.30%-13.14%
2025 Q1 report2025-04-26-¥120.72M+26.29%+11.95%+318303.78%-0.33-5.85%+4.71%+14.91%+11.67%
2024 annual report2025-04-26-¥797.27M+0.50%+1.06%+2384.10%-2.17-32.65%+4.71%+14.91%+11.67%

The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.

Stock valuations: 688443

How to read this

Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.

Figures are generated automatically from Wave Radar's published market data and refresh after each market close.